9th October 2024 – FDA grants CareLog’s Diastolic Dysfunction algorithm Breakthrough Device Designation. Press Release
revolutionizing cardiovascular diagnostics with the world’s first breakthrough ECG AI model
PRESENTING
1 million+
ECG signals from 100k+ patients for training and development of the model
4 live
deployments in collaboration with ECG manufacturers
7 partner
institutions for external validation and testing
0.80+ AUROC
score on all algorithms outperforming competitors and industry standards
Carelog’s artificial intelligence algorithm is developed with diverse datasets and is undergoing rigorous testing in real world environments. We are continuously signing agreements with institutions and care providers to extend the benefits of our product to as many patients as possible.
In today’s world, access to quality data is the factor which defines the performance of artificial intelligence algorithms. Realizing this, we have developed HridAI, the world’s first breakthrough foundational model which powers all our algorithms.
Data collection efficiency redefined
Requires just 10% of the data to train superior algorithms as compared to industry standards
Data acquisition costs redefined
Achieves superior training targets at just 10% of the costs compared to industry standards
Scalable performance across databases
Outperforms industry standard models with higher AUROC scores across multi-size datasets
Aman is a bio-engineer with 5+ years of experience in health tech. He has led developments of AI based cardiology software at Volta Medical. He is an IIT Kanpur and HEC Paris alumnus.
Sathis has 20+ years of tech experience in which he has built and scaled AI products for millions of users. He is an ex Meta Data Architect and has led 30+ tech teams during his stint as a VP at Xenovex.
Dr. Charu is a repeat entrepreneur. She sold her previous venture CardioInsight to Medtronic for $100M+. She is also the co-founder and CEO of vitalxchange.
Dr. Jag Singh is a prolific author and thought leader in the cardiology healthcare segment. He is a Professor of Medicine at the Harvard Medical School. He is also the Founding Director of the Resynchronization and Advanced Cardiac Therapeutics Program, at the Massachusetts General Hospital Heart Center.